Sacubitril/valsartan vs. angiotensin receptor inhibition in heart failure: a real‐world study in Taiwan-Reference-Cited by-同舟云学术

Sacubitril/valsartan vs. angiotensin receptor inhibition in heart failure: a real‐world study in Taiwan

Published:2020-07-28 Issue:5 Volume:7 Page:3003-3012
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Chang Po‐Cheng¹^ORCID,Wang Chun‐Li¹,Hsiao Fu‐Chih¹,Wen Ming‐Shien¹,Huang Chien‐Ying¹,Chou Chung‐Chuan¹,Chu Pao‐Hsien¹

Affiliation:

1. Division of Cardiology, Department of Internal Medicine Chang Gung Memorial Hospital, Linkou and Chang Gung University, Medical School 5 Fu‐Xing Street, Guishan District Taoyuan 33305 Taiwan

Funder

Chang Gung Medical Foundation

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12924

Reference18 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese;Woo KS;Br J Clin Pharmacol,1995

3. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

4. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

5. A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Chronic Heart Failure: A Retrospective Study at a Single Center;Medical Science Monitor;2024-06-10

2. Vericiguat suppresses ventricular tachyarrhythmias inducibility in a rabbit myocardial infarction model;PLOS ONE;2024-04-16

3. Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease;Journal of Cardiovascular Pharmacology and Therapeutics;2024-01

4. Efficacy and safety of low‐dose sacubitril/valsartan in heart failure patients: A systematic review and meta‐analysis;Clinical Cardiology;2023-01-17

5. Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials;ESC Heart Failure;2022-08-03